Abstract

Objective. To improve the investigated efficacy of treatment in elderly and senile patients, suffering the ulcer gastro-intestinal hemorrhage, in accordance to dynamics of levels of C-reactive protein, the immune system indices, and in connection with clinical picture studied.
 Materials and methods. Prospective investigation was conducted in 35 patients of elderly and senile age (in accordance to classification of The World Health Organization – 61 - 90 yrs old), suffering the ulcer gastro-intestinal hemorrhage, the course of which was complicated by cardio-vascular pathology – an acute coronary syndrome (angina pectoris, atrial fibrillation, extrasystole, arrhythmia of various genesis) and an acute myocardial infarctionі in 2019 - 2021 yrs. There were 16 (46%) women and 19 (54%) men. Average age of the patients have constituted 76.3 yrs old. This category of patients was distributed in accordance to methods of treatment of coexistent cardio-vascular pathology: Group A – 20 patients, who took hypotensive therapy in accordance to standard scheme, Group B – 15 patients, who took a «double» therapy. The control group consisted of 50 relatively healthy persons (donors), who have had approximately equal age, the gender distribution with the patients investigated, while procedure of the indices determination in them was the same.
 Results. Degree of the blood loss in accordance to classification of Marino (1998) was investigated. In Group A a small blood loss was observed in 7 (35%), and a middle one – in 13 (65%) patients. In group B big blood loss was noted in 9 (60%), while a massive one – in 6 (40%) patients. The term before admittance to hospital and preparations, which the patients took for treatment of cardio-vascular pathology – anticoagulants, antiaggregants, hypotensive, and their combinations as well – have impacted the blood loss degree. The dynamics of levels of C-reactive protein, іnterleukin-6 and іnterleukin-4 in these groups of patients was determined.
 Conclusion. On the 7th day in groups A and B normalization of levels of the acute phase index of C-reactive protein, proinflammatory interleukin-6 and proinflammatory interleukin-4 (in group B especially expressed) was not revealed. Potent interrelationship between levels of С-reactive protein and interleukin-6 was revealed, but it was statistically nonsignificant due to small size of statistical sample of the groups. Level of interleukin-4 was sharply reduced without a tendency to normalization (p <0,01). At the same time, therapy of comorbidities in patients with cardio-vascular pathology influenced a state of interleukins mentioned above. Clinical significance of immune indices was proved on multiple clinical examples and may constitute one of objective criteria for estimation of the patients’ state, prognostication of the disease course and correction of the treatment initialized.

Highlights

  • Проаналізувавши ступінь крововтрати, ми визначили, що у групі А у 7 (35%) пацієнтів була мала крововтрата, а у 13 (65%) – середня, у групі Б – у 9 (60%) пацієнтів була велика крововтрата, у 6 (40%) – масивна

  • При аналізі категорії пацієнтів з виразковою шлунково–кишкова кровотеча (ШКК) на фоні серцево–судинної патології визначено, що у групі А мала крововтрата була у 7 (35%) хворих, велика – у 13 (65%) хворих, а у групі Б велика крововтрата була у 9 (60%) хворих, масивна – у 6 (40%), що пояснюється зміною реологічних властивостей крові при застосуванні «подвійної» терапії для лікування супутньої патології

  • При великій і масивній крововтраті в даній групі пацієнтів визначено більш виражений дисбаланс рівнів гострофазного С– реактивного білка (СРБ), ІЛ–6 та ІЛ–4, що свідчить про високий ризик розвитку рецидиву кровотечі

Read more

Summary

Klinichna khirurhiia

Особливості динаміки рівня гострофазного С–реактивного білка і його зв’язок з імунною системою організму у пацієнтів з виразковою шлунково–кишковою кровотечею з супутньою серцево–судинною патологією

Dnipro State Medical University
Матеріали і методи дослідження
Ɇɚɥɚ Q
Findings
Ɇɚɫɢɜɧɚ Q

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.